After the FDA knocked the drugmaker for unsanitary standards at an Indian sterile products plant, Cipla got knocked again for not solving its issues.
The cleaning procedures are so poor at a Zydus Cadila plant in India that the FDA says a sampling found 10 different cross-contaminated products.
The European Medicines Agency has found issues at the plant of an Indian API maker that the FDA hit with a warning letter some years back.
A Recipharm plant in Sweden that was slated to close will remain open, saving 45 jobs.
U.K. authorities have cited an Apotex plant in India. The action comes even as Canadian police are probing the strangulation of the Apotex chairman.